SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001047469-99-002548
Filing Date
1999-01-28
Accepted
1999-01-28 00:00:00
Documents
3
Group Members
ORANGE ACQUISITION CORP.PEPTIDE THERAPEUTICS GROUP PLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/AMENDMENT 2 SC 13D/A 21954
2 EXHIBIT 6 EX-6 2735
3 EXHIBIT 7 EX-7 14217
  Complete submission text file 0001047469-99-002548.txt   40841
Mailing Address
Business Address 38 SIDNEY ST 4TH FLOOR CAMBRIDGE MA 02139 6175266000
ORAVAX INC /DE/ (Subject) CIK: 0000900122 (see all company filings)

IRS No.: 043085209 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48363 | Film No.: 99515688
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 321 CAMBRIDGE SCIENCE PARK MILTON ROAD CAMBRIDGE ENGLAND X0 00000 440122342333
PEPTIDE THERAPEUTICS GROUP PLC (Filed by) CIK: 0001073965 (see all company filings)